Research graph
References from Effects of blood pressure and the renin‐angiotensin system on platelet activation in type 2 diabetes. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1001/jama.287.19.2570
10.1001/jama.287.19.2570 · External reference
10.1161/01.hyp.37.4.1053
10.1161/01.hyp.37.4.1053 · External reference
10.2337/diacare.27.2007.s79
10.2337/diacare.27.2007.s79 · External reference
10.2337/diacare.13.2.153
10.2337/diacare.13.2.153 · External reference
10.2174/1381612054367337
10.2174/1381612054367337 · External reference
10.2337/diacare.26.7.2181
10.2337/diacare.26.7.2181 · External reference
10.1111/j.1538-7836.2004.00836.x
10.1111/j.1538-7836.2004.00836.x · External reference
10.1038/2151027a0
10.1038/2151027a0 · External reference
The study of platelet aggregation in whole blood
1979 · External reference
10.1007/s00592-008-0079-y
10.1007/s00592-008-0079-y · External reference
10.1055/s-0038-1648906
10.1055/s-0038-1648906 · External reference
10.1182/blood.v88.9.3456.bloodjournal8893456
10.1182/blood.v88.9.3456.bloodjournal8893456 · External reference
10.1016/s0021-9258(19)81346-7
10.1016/s0021-9258(19)81346-7 · External reference
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
1999 · External reference
10.1056/nejmoa011161
10.1056/nejmoa011161 · External reference
10.1056/nejmoa011489
10.1056/nejmoa011489 · External reference
10.2337/dc06-2493
10.2337/dc06-2493 · External reference
10.1016/s0140-6736(08)61411-7
10.1016/s0140-6736(08)61411-7 · External reference
10.1097/hjh.0b013e328277596e
10.1097/hjh.0b013e328277596e · External reference
10.1016/s0140-6736(07)61538-4
10.1016/s0140-6736(07)61538-4 · External reference
10.1161/hypertensionaha.108.124008
10.1161/hypertensionaha.108.124008 · External reference
10.1007/s10157-009-0157-7
10.1007/s10157-009-0157-7 · External reference
10.1016/j.jash.2008.05.004
10.1016/j.jash.2008.05.004 · External reference
Morning rise of systolic blood pressure (by 24‐hour ambulatory monitoring) and platelet aggregability in essential hypertension patients
2000 · External reference
10.1093/ndt/16.suppl_1.45
10.1093/ndt/16.suppl_1.45 · External reference
10.1016/j.ahj.2005.03.001
10.1016/j.ahj.2005.03.001 · External reference
10.1097/00005344-200006000-00012
10.1097/00005344-200006000-00012 · External reference
10.1016/j.amjhyper.2004.02.016
10.1016/j.amjhyper.2004.02.016 · External reference
10.1161/hypertensionaha.108.114835
10.1161/hypertensionaha.108.114835 · External reference
10.1161/01.atv.0000252064.97632.2c
10.1161/01.atv.0000252064.97632.2c · External reference
10.1056/nejm198706113162405
10.1056/nejm198706113162405 · External reference
10.1055/s-0038-1660105
10.1055/s-0038-1660105 · External reference
10.1161/01.cir.78.1.35
10.1161/01.cir.78.1.35 · External reference
The release of vesicles from platelets following adhesion to vessel walls in vitro
1972 · External reference
10.1016/s0021-9258(18)71457-9
10.1016/s0021-9258(18)71457-9 · External reference
10.1080/09537100410001682779
10.1080/09537100410001682779 · External reference
10.1016/0049-3848(93)90138-e
10.1016/0049-3848(93)90138-e · External reference
10.1038/nm1102-1227
10.1038/nm1102-1227 · External reference
10.1007/s11239-008-0301-3
10.1007/s11239-008-0301-3 · External reference
10.1161/01.hyp.0000034745.98129.ec
10.1161/01.hyp.0000034745.98129.ec · External reference
Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)‐induced vasoconstriction in canine coronary arteries and human platelet aggregation
10.1016/s0022-3565(24)35282-6 · 2000 · External reference
10.1016/j.jstrokecerebrovasdis.2007.07.003
10.1016/j.jstrokecerebrovasdis.2007.07.003 · External reference
